IL181896A0
(en )
2007-07-04
Methods and compositions for the treatment of hyperlipidemia
HK1199874A1
(en )
2015-07-24
Spiro-oxindole compounds and their uses as therapeutic agents
GB0522311D0
(en )
2005-12-07
Pharmaceutical compositions for the treatment of pain
IL208607A0
(en )
2010-12-30
Improved nanobodiestm for the treatment of aggregation-mediated disorders
PL1765391T3
(en )
2013-08-30
Bacterial compositions for the treatment of cancer
IL186615A0
(en )
2008-01-20
Spiroheterocylic compounds and their uses as therapeutic agents
PL1863899T3
(en )
2014-01-31
Skin treatment compositions
IL187405A0
(en )
2011-07-31
Methods and compositions for the treatment of pain
ZA200708033B
(en )
2008-11-26
Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
HK1111599A1
(en )
2008-08-15
Pharmaceutical compositions for the treatment of cellulite
ZA200703087B
(en )
2009-04-29
Methods and compositions for the treatment of hyperlipidemia
HK1097831A1
(en )
2007-07-06
Benzopyran compounds useful for the treatment of arrhytmia
EP1904088A4
(en )
2010-03-31
Compositions and methods for the treatment of cancer
EP1865952A4
(en )
2009-11-04
Histamine-containing composition for the treatment of allergic diseases
HU0500145D0
(en )
2005-04-28
Composition for the treatment of oral diseases
ZA200710476B
(en )
2009-10-28
Methods and compositions for the treatment of pain
ZA200606780B
(en )
2008-08-27
Compounds for the treatment of diseases
GB0313630D0
(en )
2003-07-16
Compositions for the enhanced treatment of depression
ZA200410080B
(en )
2007-03-28
Composition for the treatment of humans
HU0500947D0
(en )
2005-12-28
Composition for treatment of paradontosis
GB0505203D0
(en )
2005-04-20
Skin composition treatment
GB0602857D0
(en )
2006-03-22
The treatment of sialorrhoea
GB2441581B
(en )
2011-01-19
Compositions and methods for the treatment of muscle wasting
TJ20050863A
(en )
2007-06-05
The way of narcotism treatment
GB0423927D0
(en )
2004-12-01
The treatment of IBD